e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

News   Oct 31, 2013

 
e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE